The FDA recently approved a 200 units/mL Humalog KwikPen, a pre-filled, rapid-acting insulin pen designed to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company ...

The Humalog Junior KwikPen, a prefilled, rapid-acting insulin pen designed to improve glycemic control in people with type 1 or type 2 diabetes, is now available for prescription in the U.S., Eli ...

If you have diabetes, your doctor might suggest Humalog (insulin lispro) as a treatment option for your condition. Along with other questions you may have about the drug, you could be wondering about ...

Marks approval of first concentrated mealtime insulin analog in the U.S. and expands Lilly's portfolio of medicines for people with type 1 and type 2 diabetes INDIANAPOLIS, May 27, 2015 /PRNewswire/ - ...

Humalog (insulin lispro) is a prescription drug that’s used to help treat diabetes. Humalog comes as a liquid solution for infusion or injection under the skin. Humalog comes in two versions: Humalog ...

Humalog (insulin lispro) and Humulin N (insulin isophane human) are brand-name prescription* medications. They’re approved by the Food and Drug Administration (FDA) to help treat type 1 and type 2 ...

The InPen is for use with U-100 Lilly Humalog and Novo Nordisk Novolog rapid-acting insulin and indicated for persons aged 12 years and older. Companion Medical announced the launch of the InPen ...

The Humalog Junior KwikPen is lighter and shorter than other half-unit insulin pens. Eli Lilly announced the availability of Humalog Junior KwikPen (insulin lispro injection) 100 Units/mL for the ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Do not use if you have ever had an allergic reaction to insulin lispro ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. INDIANAPOLIS, Ind.– Indianapolis-based Eli ...

(CNN) -- Pharmaceutical company Eli Lilly will sell a cheaper generic version of its rapid-acting insulin Humalog, according to a statement Monday from Chairman and CEO Dave Ricks. At 50% the price of ...